Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

FP-101 for the Treatment of Hot Flashes in Postmenopausal Women

ClinicalTrials.gov ID: NCT03285672

Public ClinicalTrials.gov record NCT03285672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 7:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo Controlled, Single Dose-level, Proof-of-concept Study Evaluating FP-101 for the Treatment of Vasomotor Symptoms in Postmenopausal Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine the efficacy of FP-101 versus placebo for the treatment of hot flashes in postmenopausal women.

Study identification

NCT ID
NCT03285672
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Fervent Pharmaceuticals
Industry
Enrollment
109 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2018 (Actual)
Primary completion
Oct 29, 2018 (Actual)
Completion
Oct 29, 2018 (Actual)
Last update posted
Nov 1, 2018

2018

United States locations

U.S. sites
12
U.S. states
4
U.S. cities
12
Facility City State ZIP Site status
PMG Research of Christie Clinic, LLC Champaign Illinois 61820 —
PMG Research of Cary, LLC Cary North Carolina 27518 —
PMG Research of Charlotte, LLC Charlotte North Carolina 28209 —
PMG Research of Hickory, LLC Hickory North Carolina 28601 —
PMG Research of Raleigh, LLC Raleigh North Carolina 27609 —
Nash OB/GYN Rocky Mount North Carolina 27804 —
PMG Research of Salisbury, LLC Salisbury North Carolina 28144 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103 —
PMG Research of Charleston, LLC Mt. Pleasant South Carolina 29464 —
PMG Research of Bristol, LLC Bristol Tennessee 37620 —
PMG Research of Knoxville Oak Ridge Tennessee 37830 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03285672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2018 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03285672 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →